MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Weight loss: 1st commercial implant of EnteroMedics’ Maestro device

Weight loss: 1st commercial implant of EnteroMedics’ Maestro device

By

EnteroMedics announces 1st commercial implant of Maestro weight loss device

EnteroMedics (NSDQ:ETRM) said today that the first commercial patient has been implanted with its Maestro neurostimulation anti-obesity implant.

The surgery took place at Tufts Medical Center in Boston May 13, performed by Dr. Sajani Shah, EnteroMedics said.

The Maestro is designed to use what EnteroMedics calls "vBloc therapy" in which electrical pulses are used to block intra-abdominal vagus nerve signaling between the brain and stomach using a pacemaker-like device, the company said.

“Until recently, there was a great unmet need for new, alternative treatment options for obese patients for whom behavior modification, pharmaceutical options or anatomy altering/restricting surgical procedures either did not work, or were not viable options. Earlier this year, the FDA approved a first-of-its-kind treatment that offers a neuroscience-based approach to the treatment of obesity, differentiating it from traditional weight loss surgical options.  As a member of the team that brought this new device through the clinical trial phase, I am pleased to have performed the first U.S. commercial implant of vBloc therapy. At Tufts Medical Center, we are committed to staying on the leading edge of new technologies that may benefit our patients,” Shah said in a press release.

St. Paul Minn.-based EnteroMedics won FDA approval for the device in January 2015, following a mixed vote last June after the device failed to meet its efficacy endpoint in a clinical trial.

“The 1st commercial implant of vBloc therapy marks another significant milestone for EnteroMedics and the millions of individuals with obesity who may be seeking different ways of achieving safe, effective weight loss. We are pleased with the response to vBloc therapy from patients and physicians alike and remain focused on the continued development of partnerships with bariatric centers of excellence and on driving reimbursement for vBloc therapy to ensure its widespread availability in the United States,” CEO Mark Knudson said in prepared remarks.

In case you missed it

RSS From Medical Design & Outsourcing

  • Integrated Computer Solutions, Variscite to collaborate on hardware and software solution
    Integrated Computer Solutions (ICS) and Variscite announced today that they are collaborating on new solutions in the embedded market. The collaboration aims to offer a complete hardware and software solution to customers in the market, with Variscite’s SoM (system on module) solutions and ICS’ best-in-class software services set to provide a complete system solution that… […]
  • Veranex acquires medtech design firm Worrell
    Veranex today announced that it has acquired medtech design firm Worrell for an undisclosed amount. Raleigh, N.C.-based Veranex delivers strategic, operations and financial benefits to medical device companies and engineers that are developing breakthrough technologies, according to the company. The acquisition of Worrell will expand its offerings and geographic reach. “The addition of Worrell strengthens… […]
  • Movia Robotics launches TheraPal digital health aide for neurodiverse individuals
    Movia Robotics this week announced that it has launched its TheraPal line of digital health aides for autism spectrum disorder and other intellectual or developmental disabilities. Bristol, Connecticut-based Movia Robotics released its TheraPal Progress Tracker, TheraPal Home and TheraPal Clinical assist aides for use in homes and clinician offices. The robotic aides are designed to… […]
  • Instron launches Bluehill Central lab management software
    Instron announced today that it launched the Bluehill Central lab management solution for Bluehill Universal software. Norwood, Massachusetts-based Instron’s Bluehill Central platform allows lab managers to remotely manage all test systems running Bluehill Universal, regardless of the number of systems and regardless of their location around the world, according to a news release. The company… […]
  • Lenovo, LG to collaborate on radiology technology
    Lenovo and LG announced today that they are collaborating on new medical imaging solutions to aid the radiology community. According to a news release, the companies will work together to bundle LG’s high-performance medical monitors with the Lenovo original equipment manufacturer (OEM) solutions commercial third-party portfolio of offerings. Get the full story at our sister… […]
  • Baxter, 3M, Abbott near the top of Newsweek’s most responsible companies list
    Several medtech, healthcare and life sciences companies, including big names like Abbott (NYSE:ABT), 3M (NYSE:MMM) and Baxter (NYSE:BAX), are among the 500 “most responsible,” according to Newsweek. The outlet published its “America’s Most Responsible Companies 2022” list, marking the third installment of the compilation (in partnership with Statista), this time expanded to include 500 of the largest public corporations around. Companies were judged with… […]
  • HHS reports 63-fold increase in telehealth use during pandemic
    A new study from the U.S. Department of Health and Human Services found a 63-fold increase in Medicare telehealth use during the COVID-19 pandemic. The report analyzed Medicare fee-for-service data from 2019 and 2020 and highlighted that people in urban areas were more likely to seek and use telehealth services than rural residents. In addition,… […]
  • Carlyle makes a significant investment in Resonetics
    Carlyle-managed funds have acquired a significant interest in medical device contract manufacturer Resonetics. Today’s announcement did not include the investment size, but the deal values Nashua, New Hampshire–based Resonetics at roughly  $2.25 billion. Carlyle joins existing investor GTCR as a meaningful shareholder in the company. Resonetics focuses on producing highly technical components for medical device… […]
  • Interpreting Pump Performance Curves
    Reading pump performance curves is crucial to proper pump selection. This piece reviews the creation and use of diaphragm pump performance curves to determine flow at given vacuum or pressure conditions. Included is a lesser-known method to interpolate pump performance when flow restrictions exist on both the inlet and outlet sides of the pump. Download… […]
  • BD elaborates on diversity and equity goals
    BD (NYSE:BDX) earlier this week outlined its efforts this year related to global inclusion, diversity and equity. Franklin Lakes, New Jersey-based BD released its 2021 Global Inclusion, Diversity and Equity (ID&E) Report, highlighting the progress it’s made in human health as part of its environmental, social and governance (ESG) strategy, according to a news release.… […]
  • How to protect medical devices from hidden cybersecurity risks
    Your software supply chain could be a cybersecurity risk. Here’s what you can do. Vince Arneja, GrammaTech The healthcare industry has been fighting a war on two fronts during the COVID-19 pandemic against the virus and an outbreak of cyberattacks. The Department of Health and Human Services says the sector reported a 9,851% increase in… […]

Leave a Reply